Hercules Capital, Inc.
HTGC NYSE Financials FY2020–FY2025
Last close · Oct 23, 2026
$16.41
0.5%What Hercules Capital, Inc. does
No business description yet.
- Legal name
- Hercules Capital, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 12, 2026
- Accession · CIK
- 0001280784-26-000009
0001280784
Revenue and margins
Hercules Capital, Inc. had $532M of revenue in fiscal 2025, up 7.9% on the year before.
Net income and earnings per share
From fiscal 2020 to 2025, diluted EPS grew −1.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$426M in fiscal 2025, −80.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hercules Capital, Inc. returned $332M to shareholders in fiscal 2025. The diluted share count rose 16.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Hercules Capital, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $133M | $14.6M | $98.1M | $42.7M | $57.0M |
| Debt incl. finance leases | $1.2B | $1.6B | $1.6B | $1.8B | $2.3B |
| Debt / equity | 0.9x | 1.1x | 0.9x | 0.9x | 1.0x |
| Total assets | $2.6B | $3.0B | $3.4B | $3.8B | $4.6B |
| Total liabilities | $1.3B | $1.6B | $1.6B | $1.8B | $2.4B |
| Shareholders' equity | $1.3B | $1.4B | $1.8B | $2.0B | $2.2B |
| Net debt (− = net cash) | $1.1B | $1.6B | $1.5B | $1.7B | $2.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ |
| Return on assets rose | — | — | ✕ | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Debt fell relative to assets | — | — | ✕ | ✓ | ✕ | ✕ |
| Current ratio rose | — | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✕ | ✓ | ✕ | ✕ |
| F-score | — / 3 | — / 4 | 1 / 7 | 5 / 7 | 1 / 7 | 2 / 7 |
| Accruals ratio | — | 1.8% | 18.7% | 8.4% | 10.5% | 18.2% |
| Altman Z'' | — | — | — | — | — | — |
6 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $287M | $281M | $322M | $461M | $494M | $532M |
| Interest expense | $66.9M | $67.5M | $62.3M | $77.5M | $77.2M | $92.2M |
| Net income | $227M | $174M | $102M | $337M | $263M | $340M |
| Net income to common | — | $172M | $99.9M | $334M | $260M | $337M |
| Diluted EPS | $2.01 | $1.49 | $0.79 | $2.31 | $1.61 | $1.85 |
| Diluted shares | 0.11B | 0.12B | 0.13B | 0.14B | 0.16B | 0.19B |
| Cash flow | ||||||
| Cash from operations | $208M | $129M | −$425M | $68.3M | −$118M | −$426M |
| Capital expenditure | $0.1M | $0.1M | $0.1M | $0.9M | $0.7M | $0.1M |
| Free cash flow | $208M | $129M | −$425M | $67.4M | −$119M | −$426M |
| Depreciation and amortization | $0.4M | $0.3M | $0.2M | $0.2M | $0.5M | $0.3M |
| Stock-based compensation | $8.5M | $10.4M | $10.8M | $11.9M | $12.5M | $14.8M |
| Share buybacks | $1.8M | $2.8M | $4.5M | $12.7M | $3.4M | $6.5M |
| Dividends paid | $152M | $176M | $245M | $274M | $303M | $326M |
| Dividends and buybacks | $154M | $178M | $250M | $286M | $307M | $332M |
| Balance sheet | ||||||
| Cash and short-term investments | $198M | $133M | $14.6M | $98.1M | $42.7M | $57.0M |
| Total debt | — | $1.2B | $1.6B | $1.6B | $1.8B | $2.3B |
| Total assets | — | $2.6B | $3.0B | $3.4B | $3.8B | $4.6B |
| Total liabilities | — | $1.3B | $1.6B | $1.6B | $1.8B | $2.4B |
| Shareholders' equity | $1.3B | $1.3B | $1.4B | $1.8B | $2.0B | $2.2B |
| Margins | ||||||
| Net margin | 79.1% | 62.0% | 31.7% | 73.3% | 53.3% | 63.8% |
| FCF margin | 72.3% | 45.7% | −132.1% | 14.6% | −24.1% | −80.0% |
| Returns | ||||||
| Return on equity | 17.6% | 13.4% | 7.5% | 21.1% | 13.9% | 16.2% |
| Return on assets | — | 6.7% | 3.6% | 10.5% | 7.3% | 8.1% |
| Return on tangible equity | 17.6% | 13.2% | 7.1% | 18.5% | 13.1% | 15.2% |
| Growth | ||||||
| Revenue growth | — | −2.2% | 14.5% | 43.2% | 7.1% | 7.9% |
| Net income growth | — | −23.4% | −41.4% | 230.6% | −22.1% | 29.2% |
| EPS growth | — | −25.9% | −47.0% | 192.4% | −30.3% | 14.9% |
| FCF growth | — | −38.1% | −430.6% | — | −276.3% | — |
| Share count change | — | 3.3% | 9.2% | 14.3% | 11.6% | 16.9% |
| Financial health | ||||||
| Debt / equity | — | 0.9x | 1.1x | 0.9x | 0.9x | 1.0x |
| Capital allocation | ||||||
| Capex / revenue | 0.0% | 0.0% | 0.0% | 0.2% | 0.1% | 0.0% |
| Stock comp / revenue | 2.9% | 3.7% | 3.4% | 2.6% | 2.5% | 2.8% |
| Payouts / FCF | 74.3% | 138.8% | — | 425.0% | — | — |
| Quality scores | ||||||
| Piotroski F-score | — | — | 1.0 | 5.0 | 1.0 | 2.0 |
| Accruals ratio | — | 1.8% | 18.7% | 8.4% | 10.5% | 18.2% |
Source: SEC EDGAR XBRL filings (CIK 0001280784). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
